{"id":"W2908699784","doi":"10.1007/s10549-018-05125-4","title":"Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; Breast cancer; Oncology; Internal medicine; Placebo; Metastatic breast cancer; Hazard ratio; Estrogen receptor; Population; Cancer; Gynecology; Tamoxifen; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001221369,0.0004765534,0.001308603,0.0003654525,0.000202792,0.0004160695,0.000481931,0.0003632556,0.001788722],"category_scores_gemma":[0.0007147255,0.0002018383,0.0009134794,0.0004044871,0.0002691733,0.0003933063,0.0002412919,0.0009909832,0.0003001369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006856638,"about_ca_system_score_gemma":0.0008955521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006850861,"about_ca_topic_score_gemma":0.003038975,"domain_scores_codex":[0.9996709,0.0001635446,0.00002060344,0.00004837938,0.00005693828,0.00003961804],"domain_scores_gemma":[0.9996983,0.00007579641,0.0000800675,0.00003166917,0.00002124392,0.0000929384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7474058,0.0107898,0.01735807,0.001056236,0.002350348,0.0002554793,0.0001119572,0.002145939,0.01828446,0.0001114201,0.001600757,0.1985297],"study_design_scores_gemma":[0.5469165,0.3427089,0.09221502,0.0001636563,0.002716458,0.0008010418,0.00006931113,0.002547687,0.006537898,0.0002730345,0.00501365,0.00003690528],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991576,0.005715855,0.0002632643,0.0001666722,0.00004744855,0.0006034967,0.0004234433,0.00004516261,0.00115879],"genre_scores_gemma":[0.9957513,0.001838222,0.0004941089,0.0001773139,0.00006079443,0.000457048,0.0006021333,0.000005668142,0.0006134352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001788722,"threshold_uncertainty_score":0.006459296,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03527075155297768,"score_gpt":0.3551255762284284,"score_spread":0.3198548246754507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}